Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Dachille Douglas A.

Over the trailing 90 days, Dachille Douglas A. (Director at BridgeBio Pharma, Inc.) bought $198K of stock across 3 companies, per 4 SEC Form 4 transactions.

Role: Director
Companies: BBIO PNC EQH
Window: Trailing 90 days · 4 transactions · CIK 1652908
Net activity: +$198K ($198K bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
EQH	Equitable Holdings, Inc.	1	$185K	—	$185K
PNC	PNC FINANCIAL SERVICES GROUP, INC.	1	$13K	—	$13K
BBIO	BridgeBio Pharma, Inc.	2	—	—	$0

Transactions (4)

Date	Symbol	Type	Shares	Value	Description
2026-07-01	PNC	Buy	51	$13K	Grant, award or other acquisition
2026-06-22	BBIO	Buy	4.0K	$0	Grant, award or other acquisition
2026-06-22	BBIO	Buy	5.3K	$0	Grant, award or other acquisition
2026-05-20	EQH	Buy	4.4K	$185K	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Dachille's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free